An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
NCT00199381
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
504
Enrollment
INDUSTRY
Sponsor class
Stopped
Additional long-term safety data no longer needed
Conditions
Parkinson's Disease
Interventions
DRUG:
Istradefylline
Sponsor
Kyowa Kirin, Inc.
Collaborators
[object Object]